BASEL, Switzerland: With implant dentistry continually developing and evolving, so too are some of the low-cost options. In a recent move to secure a larger stake in that market, Straumann recently signed agreements to buy further shares in T-Plus, a Taiwanese dental implant manufacturer. Once the Taiwanese Investment Commission has approved the purchase, Straumann will gain a 60 per cent share in the company.
T-Plus develops and manufactures attractively priced dental implant systems, which are sold exclusively through distributors in Taiwan and China. Its portfolio includes three tapered implant designs and covers a broad range of indications and customer preferences. The concepts, features and quality are similar to those of popular implant brands, something that Straumann believes makes T-Plus an attractive, inexpensive option for dentists using systems like Osstem and Astra.
Straumann first entered the non-premium market two years ago with a 30 per cents take in the France-based dental implant systems manufacturer Anthogyr. They have now reported that in Asia more than six million non-premium implants are sold annually, of which more than a third are low-cost.
“T-Plus provides us with the additional product ranges, registrations and brand to penetrate the entire non-premium segment in Taiwan and mainland China. In addition, it provides us with a modern, certified manufacturing facility in Asia. The company has a good track record and is well positioned for international growth, supported by the Straumann Group’s global presence, network and expertise,” said Patrick Loh, Head of Sales in Asia Pacific.
Tags:
BASEL, Switzerland: The Straumann Group is introducing two organisational changes to support the development of its fast-growing orthodontics and digital ...
BASLE, Switzerland: Straumann is pleased to offer its new Straumann BLX implant system across the whole of Europe. The next-generation solution for ...
BASEL, Switzerland/TIANJIN, China: The Straumann Group will be partnering with Tianjin ZhengLi Technology, whose clear aligner system has regulatory ...
The following case report describes a successful immediate implant placement in a mandibular first molar position with Straumann TLX and an immediately ...
BASEL, Switzerland: Biomaterials can often play a key role in many regenerative and restorative therapeutic approaches in dentistry. Proper understanding of...
BASEL, Switzerland: The Straumann Group has posted strong financial results for the first half of 2019, with organic revenue up around 16%. Founding new ...
PALMA DE MALLORCA, Spain: From 1 to 3 December, global dental implants manufacturer Straumann will be holding its first International Esthetic Days congress...
Straumann, one of the leading companies in implant dentistry, will be holding the Global Straumann Biomaterials Virtual Symposium to foster clinical ...
BURNABY, British Columbia, Canada: According to a new market report by iData Research, a leading provider of international dental market research, the Asia ...
BASEL, Switzerland: The COVID-19 pandemic has now spanned 15 months, meaning that the latest quarterly results posted by dental companies are no longer ...
Live webinar
Mon. 2 September 2024
5:00 am EST (New York)
Live webinar
Tue. 3 September 2024
11:00 am EST (New York)
Live webinar
Thu. 19 September 2024
8:00 pm EST (New York)
Live webinar
Wed. 9 October 2024
11:00 am EST (New York)
Live webinar
Thu. 10 October 2024
9:00 am EST (New York)
Dr. Krzysztof Chmielewski, Dr. Alejandro Lanis, Dr. Sergio Piano, Dr. Jochen Tunkel CODE expert, Prof. Hani Tohme, Dr. Kimberly Schlam DMD, MS
Live webinar
Thu. 7 November 2024
12:00 pm EST (New York)
Dr. Nikolay Makarov DDS, MSC, PhD.
Dr. Oscar González-Martín DDS, PhD, MSc., Dr. Acela Martinez, Dr. Massimo Frosecchi, Dr. Algirdas Puisys, Dr. Ghida Lawand BDS, MSc, Dr. Eglė Vindašiūtė-Narbutė
To post a reply please login or register